Skip to main content
Fig. 8 | Allergy, Asthma & Clinical Immunology

Fig. 8

From: Anti-asthmatic miR-224-5p inhibits the FHL1/MAPK pathway to repress airway smooth muscle cell proliferation in a murine model of asthma-like airway inflammation

Fig. 8

MiR-224-5p blocks the MAPK pathway activation by inhibiting FHL1 in vivo. Asthmatic mice were treated with lentivirus harboring miR-224-5p-agomir/NC-agomir or in combination with lentivirus harboring oe-FHL1/oe-NC. A Expression of miR-224-5p, FHL1, ERK, p38MAPK, and JNK in lung tissues of asthmatic mice determined by RT-qPCR. B Protein levels of FHL1, ratio of p-ERK/ERK, ratio of p-p38MAPK/p38MAPK, and ratio of p-JNK/JNK in lung tissues of asthmatic mice determined by Western blot analysis. C Protein expression of p-ERK, p38MAPK, and p-JNK in lung tissues of asthmatic mice detected by immunohistochemical analysis. n = 10 mice for each treatment. * p < 0.05 compared with asthmatic mice treated with lentivirus harboring NC-agomir. # p < 0.05 compared with asthmatic mice treated with lentivirus harboring miR-224-5p-agomir + oe-NC

Back to article page